Convelo Therapeutics, Inc Email Format

Biotechnology ResearchOhio, United States2-10 Employees

Convelo Therapeutics, Inc. operates in the biotechnology research sector with a focus on restoring the regenerative capacity of the central nervous system. The company concentrates on rebuilding the myelin coating surrounding nerve cells, aiming to address a range of neurological conditions that include multiple sclerosis, pediatric leukodystrophies, traumatic injury, and age-related diseases such as Alzheimer’s. Its work centers on identifying biological targets and advancing a pipeline of drug candidates intended to provide new therapeutic options for patients and their families.
Based in Cleveland, Ohio, Convelo is positioned as a specialized player pursuing treatments that promote myelin repair. The organization has publicly discussed progress toward oral therapies, including preclinical demonstrations of potential effectiveness in models relevant to MS. Its partnerships and collaborative efforts, including a notable relationship established in 2022, reflect its approach within the broader biotechnology landscape focused on central nervous system regeneration.

Get verified Convelo Therapeutics, Inc emails free

Company overview Employee directory